Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» mosunetuzumab
mosunetuzumab
ASH: Roche uncorks eyepopping responses in bispecific test, hoping to add a jewel to its future portfolio
Endpoints
Sun, 12/12/21 - 11:31 pm
ASH2021
Roche
Genentech
bispecific antibodies
blood cancer
mosunetuzumab
ASH: Roche bispecific delivers for hard-to-treat lymphoma patients failed by CAR-Ts
Fierce Biotech
Mon, 12/9/19 - 09:48 am
Roche
ASH2019
non-Hodgkin lymphoma
mosunetuzumab